Related Experiment Video
Updated: Jun 9, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Postmenopausal Osteoporosis, Endothelial Dysfunction, and Cardiovascular Risk
Marie-Eva Pickering1,2, Christian Heiss3,4, Véronique Morel5
1Rheumatology Department, CHU Clermont-Ferrand.
Insights
Endothelial function in postmenopausal osteoporosis patients provides additional cardiovascular risk insights. Bisphosphonate use may positively impact endothelial function, warranting cautious cardiovascular follow-up.
Area of Science:
- Endocrinology
- Cardiology
- Gerontology
Background:
- Bone and cardiovascular health are closely linked.
- The relationship between endothelial function, osteoporosis, and cardiovascular disease in postmenopausal women is not fully understood.
- This study investigates endothelial function in relation to bone health and cardiovascular risk in osteoporosis.
Purpose of the Study:
- To assess endothelial function using flow-mediated dilation (FMD) in postmenopausal women with osteoporosis.
- To explore associations between FMD, bone turnover markers, bone mineral density, and fracture history.
- To determine the relationship between FMD and cardiovascular disease risk scores (SCORE2/2-OP).
Main Methods:
- A cohort of 111 postmenopausal women with osteoporosis was recruited.
- Flow-mediated dilation (FMD) was measured at the brachial artery.
- Statistical analyses examined correlations between FMD and bone parameters, bisphosphonate use, and SCORE2/2-OP.
Main Results:
- No significant associations were found between FMD and bone mineral density or bone turnover markers.
- FMD showed a positive association with prior bisphosphonate use (r=0.270, p=0.007).
- FMD was inversely associated with SCORE2/2-OP (r=-0.212, p=0.035), especially in younger participants. Many patients had high cardiovascular risk or low FMD despite low/intermediate risk scores.
Conclusions:
- Endothelial function assessment offers valuable information beyond traditional cardiovascular risk factors in postmenopausal osteoporosis.
- Findings suggest potential benefits of bisphosphonates on endothelial function.
- Cautious cardiovascular monitoring is recommended for osteoporotic patients, even those with initially low cardiovascular risk.
Background/Objectives:
Bone and cardiovascular health are interconnected, yet their relationship with endothelial function in postmenopausal osteoporosis remains insufficiently understood. This study aimed to investigate, in women with osteoporosis, the associations between endothelial function, assessed by flow-mediated dilation (FMD), bone turnover, and cardiovascular disease risk.
Methods:
This cohort study included consecutive postmenopausal osteoporosis outpatients from the Rheumatology Department of Clermont-Ferrand University Hospital, France. FMD was measured at the brachial artery and values contextualized with age-matched healthy women's data reported in the literature. Associations between FMD and bone-related parameters (bone mineral density, bone markers, fracture history, and treatments), and Systematic Coronary Risk Evaluation (SCORE2/2-OP) were analyzed.
Results:
A total of 111 postmenopausal women with osteoporosis (mean age 69.4 ± 7.9 y; mean FMD=3.14 ± 2.28%) were included. No significant associations were found between FMD and bone-related parameters. FMD was positively associated with prior bisphosphonate use ( r =0.270, p =0.007) and inversely associated with SCORE2/2-OP ( r =-0.212, p =0.035), particularly among younger participants. Overall, 49.5% of patients had high/very high SCORE2/2-OP, and 55% of those classified as low/intermediate SCORE2/2-OP exhibited low FMD values.
Conclusions:
Measurement of the endothelial function in postmenopausal osteoporosis brings additional information to cardiovascular risk calculation, suggesting that factors beyond traditional cardiovascular risk determinants contribute to vascular impairment. In clinical practice, our findings support cautious cardiovascular follow-up even in osteoporotic patients with low cardiovascular risk and underline possible positive effects of bisphosphonates on endothelial function.
Related Concept Videos
Menopause
Coronary Artery Disease I: Introduction
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Coronary Artery Disease II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Peripheral Artery Disease I: Introduction
